09:49:16 EDT Mon 23 May 2022
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

SEC defendant Giguiere facing 27-month jail term

2022-05-10 20:45 ET - Street Wire

Also Street Wire (U-KVMD) Kelvin Medical Inc

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

California prosecutors have requested a 27-month jail term for Gannon Giguiere, a California stock tout charged alongside Vancouver's Oliver Lindsay for a $1.4-million OTC Markets scheme. (All figures are in U.S. dollars.) They say that he was part of a "classic pump-and-dump" that met with considerable success. He and others were able to boost a supposed medical device company through a touting website he owned and through manipulative trades, the government says.

The request from prosecutors comes as part of a case in which they cited Mr. Giguiere, operator of a touting website called TheMoneyStreet, for the promotion of a company called Kelvin Medical Inc. The government claimed that he and Mr. Lindsay boosted the stock to $1.70 while he unloaded improperly issued shares. There was no trial for Mr. Giguiere, as he pleaded guilty on July 19, 2019.

The proposed sentence is contained in a memorandum filed on May 5, 2022, in federal court in California. In addition to the 27-month jail term, prosecutors are seeking forfeiture of assets, restitution and a $10,000 fine. They are also asking for three years of supervised release.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2022 Canjex Publishing Ltd. All rights reserved.


Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.